Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

AEterna Zentaris completes patient recruitment into phase III safety trial of cetrorelix in BPH

Dec. 19, 2008

Omeros presents results from phase I OMS-201 study

Dec. 12, 2008

New treatment options for genitourinary disorders reported in recent Japanese patents

Dec. 11, 2008

EA-230 attenuates acute renal failure in vivo

Dec. 3, 2008

ONO-1301MS may improve tubulointerstitial injury in chronic kidney disease

Dec. 2, 2008

Streptococcal endopeptidase IdeS prevents experimental glomerulonephritis

Dec. 2, 2008

SBR-759 lowers serum phosphorus in dialysis patients

Dec. 1, 2008

Protox reports positive results from phase II study of PRX-302 in BPH

Nov. 28, 2008

Recordati files MAA in Europe for silodosin for benign prostatic hyperplasia

Nov. 27, 2008

Novel PGE2 receptor modulators emerge from Astellas R&D

Nov. 27, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...